Dr. Peter Kang
Dr. Kang is a pediatric neurologist and physician-scientist whose clinical and research interests focus on neuromuscular disorders. He has been Chief of the Division of Pediatric Neurology since 2013 and Director of the Pediatric Neurology Residency Program since 2016. During this period, three new faculty members have joined the Division, and the residency program has grown and matured rapidly. All faculty members are contributing to the development of additional subspecialty clinics and the enhancement of education at the resident, fellow, and medical student levels.
Dr. Kang’s research laboratory focuses on the genetics of muscular dystrophy and other pediatric neuromuscular disorders, and he has published extensively on these subjects. His work is supported by the National Institutes of Health and was previously supported by the Muscular Dystrophy Association. Among his former trainees, several are faculty members in the United States, Canada, and South Korea.
Dr. Kang is a Fellow of the American Academy of Pediatrics and the American Academy of Neurology, serving on national committees for both organizations. He is a member of the Board of Directors of the Child Neurology Society, and serves on the editorial boards of Muscle & Nerve, Neurology, Pediatric Neurology, and Pediatrics. He completed medical school at the University of Pennsylvania, pediatric residency at Yale-New Haven Hospital, a pediatric neurology residency at the University of Pennsylvania and a fellowship in clinical neurophysiology at Beth Israel Deaconess Medical Center. Prior to his arrival at UF in 2013, Dr. Kang was an Associate Professor of Neurology at Harvard Medical School and the Director of the Electromyography Laboratory at Boston Children’s Hospital.
- Muscular dystrophy
- Myasthenia gravis
- Electromyography (EMG)
- Cockayne syndrome
- Gene discovery in muscular dystrophy using linkage analysis and next generation sequencing
- Muscle biology of MEGF10